Skip Navigation


Carcinogenesis Advance Access originally published online on February 2, 2007
Carcinogenesis 2007 28(6):1277-1286; doi:10.1093/carcin/bgm024
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/6/1277    most recent
bgm024v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shankar, S.
Right arrow Articles by Srivastava, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shankar, S.
Right arrow Articles by Srivastava, R. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa

Sharmila Shankar and Rakesh K. Srivastava*

Department of Biochemistry, University of Texas Health Center at Tyler, Tyler, TX 75703, USA

* To whom correspondence should be addressed at Department of Biochemistry and Molecular Biology, The University of Texas Health Center at Tyler, 11937 US Highway 271, Tyler, TX 75708-3154, USA. Tel: +903 877 7559; Fax: +903 877 5320; Email: rakesh.srivastava{at}uthct.edu

Curcumin, an active ingredient of turmeric (Curcuma longa), inhibits proliferation and induces apoptosis in cancer cells, but the sequence of events leading to cell death is poorly defined. The objective of this study was to examine the molecular mechanisms by which multidomain pro-apoptotic Bcl-2 family members Bax and Bak regulate curcumin-induced apoptosis using mouse embryonic fibroblasts (MEFs) deficient in Bax, Bak or both genes. Curcumin treatment resulted an increase in the protein levels of both Bax and Bak, and mitochondrial translocation and activation of Bax in MEFs to trigger drop in mitochondrial membrane potential, cytosolic release of apoptogenic molecules [cytochrome c and second mitochondria-derived activator of caspases (Smac)/direct inhibitor of apoptosis protein-binding protein with low isoelectric point], activation of caspase-9 and caspase-3 and ultimately apoptosis. Furthermore, MEFs derived from Bax and Bak double-knockout (DKO) mice exhibited even greater protection against curcumin-induced release of cytochrome c and Smac, activation of caspase-3 and caspase-9 and induction of apoptosis compared with wild-type MEFs or single-knockout Bax–/– or Bak–/– MEFs. Interestingly, curcumin treatment also caused an increase in the protein level of apoptosis protease-activating factor-1 in wild-type MEFs. Smac N7 peptide enhanced curcumin-induced apoptosis, whereas Smac siRNA inhibited the effects of curcumin on apoptosis. Mature form of Smac sensitized Bax and Bak DKO MEFs to undergo apoptosis by acting downstream of mitochondria. The present study demonstrates the role of Bax and Bak as a critical regulator of curcumin-induced apoptosis and over-expression of Smac as interventional approaches to deal with Bax- and/or Bak-deficient chemoresistant cancers for curcumin-based therapy.

Abbreviations: Apaf-1, apoptosis protease-activating factor-1; DAPI, 4'-6-Diamidino-2-phenylindole; DIABLO, direct inhibitor of apoptosis protein-binding protein with low isoelectric point; DKO, double knockout; DMSO, dimethyl sulfoxide; FITC, fluorescein isothiocyanate; IAP, inhibitor of apoptosis protein; MEF, mouse embryonic fibroblast; OMM, outer mitochondrial membrane; PARP, poly-ADP ribose polymerase; PBS, phosphate-buffered saline; Smac, second mitochondria-derived activator of caspase; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand

Received October 20, 2006; revised January 10, 2007; accepted January 17, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Shankar, S. Ganapathy, and R. K. Srivastava
Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
Clin. Cancer Res., November 1, 2008; 14(21): 6855 - 6866.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. R. Hussain, M. Ahmed, N. A. Al-Jomah, A. S. Khan, P. Manogaran, M. Sultana, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin
Curcumin suppresses constitutive activation of nuclear factor-{kappa}B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines
Mol. Cancer Ther., October 1, 2008; 7(10): 3318 - 3329.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.